Efficacy and safety of the combination of encorafenib and cetuximab in patients with BRAF V600E mutated metastatic colorectal cancer: An AGEO real-world multicentre study

被引：2

作者：

Gallois, C. ^{[1
]}

Elez Fernandez, M. E. ^{[2
]}

Auclin, E. ^{[3
]}

Bergen, E. S. ^{[4
]}

Pernot, S. ^{[5
]}

Higue, J. ^{[6
]}

Trouilloud, I. ^{[7
]}

Touchefeu, Y. ^{[8
]}

Turpin, A. ^{[9
]}

Mazard, T. ^{[10
]}

Pilla, L. ^{[1
]}

Cuissy, S. ^{[11
]}

Wookey, V. ^{[12
]}

Perret, A. ^{[13
]}

Melchior, C. ^{[14
]}

Artru, P. ^{[15
]}

Stintzing, S. ^{[16
]}

Dubreuil, O. ^{[17
]}

Tougeron, D. ^{[18
]}

Taieb, J. ^{[19
]}

机构：

[1] Hop Europeen Georges Pompidou, AP HP, Digest Oncol Dept, Paris, France

[2] Vall dHebron Univ Hosp, Dept Med Oncol, Barcelona, Spain

[3] Hop Europeen Georges Pompidou, AP HP, Oncol Dept, Paris, France

[4] Univ Kliniken MedUni Wien AKH Wien, Div Oncol, Dept Med 1, Vienna, Austria

[5] Inst Bergonie, Digest Med Oncol Unit, Bordeaux, France

[6] Inst Univ Canc Toulouse Oncopole, Haute Garonne, Toulouse, France

[7] Hop St Antoine, Med Oncol Dept, Paris, France

[8] CHU Nantes, Digest Oncol, Hotel Dieu, Nantes, France

[9] CHU Lille, Dept Med Oncol, Lille, France

[10] Inst Canc Montpellier, Med Oncol, Montpellier, France

[11] CHU Rouen Normandie, Seine Maritime, Rouen, France

[12] Mayo Clin, Dept Oncol, Rochester, MN USA

[13] Inst Gustave Roussy, Digest Oncol Dept, Villejuif, France

[14] Ctr Leon Berard, Digest Oncol Dept, Lyon, France

[15] Hop Prive Jean Mermoz, GI Oncol Dept, Lyon, France

[16] Charite Univ Med Berlin, Hematol Oncol & Canc Immunol CCM Dept, Berlin, Germany

[17] Gh Diaconesses Croix St Simon, Med Oncol, Paris, France

[18] CHU Poitiers, Dept Gastroenterol & Hepatol, Jean Bernard Hop, Poitiers, France

[19] Hop European George Pompidou, Gastroenterol & Digest Oncol Dept, Paris, France

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.1816

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

625P

引用

页码：S446 / S446

页数：1

共 50 条

[11] Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E Mutation
Zaina T. Al-Salama
Drugs, 2021, 81 : 849 - 856
[12] Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E Mutation
Al-Salama, Zaina T.
DRUGS, 2021, 81 (07) : 849 - 856
[13] Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer Reply
Gardner, Caleb
Kleinman, Arthur
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (09): : 880 - 880
[14] Cetuximab every second week in combination with daily encorafenib in patients with BRAF V600E mutated metastatic colorectal cancer: Interim analysis from NEW BEACON.
Eriksen, Martina
Pfeiffer, Per
Rohrberg, Kristoffer Staal
Yde, Christina Westmose
Petersen, Lone Norgard
Poulsen, Laurids
Qvortrup, Camilla
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 153 - 153
[15] Treatment of metastatic colorectal cancer with BRAF V600E mutation: A multicenter real-world study in China
Xu, Yuqiu
Wang, Guiying
Zheng, Xuzhi
Chang, Wenju
Fu, Jihong
Zhang, Tao
Lin, Qi
Lv, Yang
Zhu, Zhehui
Tang, Wentao
Xu, Jianmin
EJSO, 2023, 49 (11):
[16] Encorafenib, binimetinib, and cetuximab in BRAF V600E–mutated colorectal cancer: an early post-marketing phase vigilance study
Hidenori Sakata
Maki Murase
Takeshi Kato
Kensei Yamaguchi
Kenichi Sugihara
Shigenobu Suzuki
Takayuki Yoshino
International Journal of Clinical Oncology, 2023, 28 : 139 - 144
[17] Encorafenib and cetuximab versus irinotecan/cetuximab or FOLFIRI/cetuximab in Chinese patients with BRAF V600E mutant metastatic colorectal cancer: The NAUTICAL CRC study.
Wang, Xicheng
Deng, Yanhong
Zhang, Yanqiao
Liu, Tianshu
Yuan, Xianglin
Yang, Jianwei
Zhang, Tao
Zang, Ai-min
Liu, Yu
Huang, Li
Ye, Feng
Zong, Hong
Ba, Yi
Klauck, Isabelle
Vedovato, Jean-Claude
Groc, Melanie
Guo, Angela
Shen, Lin
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (17_SUPPL) : LBA3559 - LBA3559
[18] Survival of patients (pts) with BRAF V600E mutated metastatic colorectal cancer (mCRC) treated with systemic therapy in a real-world setting
Gotz, Moritz
Kasper, Stefan
Paul, Andreas
Markus, Peter
Schumacher, Brigitte
Albers, David
Rosery, Vivian
Laue, Katharina
Zaun, Gregor
Kostbade, Karina
Pogorzelski, Michael
Schmid, Kurt Werner
Schildhaus, Hans-Ulrich
Wiesweg, Marcel
Schuler, Martin
Virchow, Isabel
ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 65 - 66
[19] Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study
Cremolini, Chiara
Pietrantonio, Filippo
Tomasello, Gianluca
Dadduzio, Vincenzo
Moretto, Roberto
Morano, Federica
Schirripa, Marta
Antoniotti, Carlotta
Fuca, Giovanni
Bergamo, Francesca
Rossini, Daniele
Nichetti, Federico
Ziampiri, Stamatia
Ghidini, Michele
Marmorino, Federica
Prisciandaro, Michele
Falcone, Alfredo
De Braud, Filippo
Loupakis, Fotios
Lonardi, Sara
ESMO OPEN, 2017, 2 (03)
[20] Pilot study of vemurafenib and panitumumab combination therapy in patients with BRAF V600E mutated metastatic colorectal cancer.
Yaeger, Rona D.
Cercek, Andrea
O'Reilly, Eileen Mary
Reidy, Diane Lauren
Kemeny, Nancy E.
Wolinsky, Tamar
Gollub, Marc J.
Lacouture, Mario E.
Rosen, Neal
Vakiani, Efsevia
Saltz, Leonard
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)

← 1 2 3 4 5 →